Sign In
Buy MRNA
$51.59
+2.53 (+5.16%)
At Close: Jun 04, 2026
3 Unstoppable Dow Dividend Kings to Boost Your Passive Income Stream
12:00pm, Saturday, 30'th Apr 2022 The Motley Fool
These dividend stocks are breaking out toward new all-time highs.
Pfizer (PFE) to Report Q1 Earnings: What's in the Cards?
03:56pm, Friday, 29'th Apr 2022 Zacks Investment Research
Revenues from the COVID-19 vaccine and COVID pill, Paxlovid are likely to have driven Pfizer's (PFE) sales in the first quarter.
2 Charts That Every Biotech Investor Must See
03:00pm, Friday, 29'th Apr 2022 The Motley Fool
Making drugs is getting harder, and it might not get easier anytime soon.
Thinking of Buying BioNTech? Consider These 3 Things First
02:45pm, Friday, 29'th Apr 2022 The Motley Fool
There's trouble ahead, but a few new solutions are on the way too.
Pandemic is not over yet, says Dr. Fauci, and WHO says omicron accounted for 99.7% of all cases sequenced in latest week
11:25am, Friday, 29'th Apr 2022 MarketWatch
Just hours after saying the U.S. was out of the "pandemic phase," Dr. Anthony Fauci, President Joe Biden's chief medical adviser and a leading infectious disease expert, clarified that he should have
Why Are Dolly Parton And Elon Musk Trending Together On Twitter?
10:19pm, Thursday, 28'th Apr 2022 Benzinga
Dolly Parton and Elon Musk have rarely been mentioned together in the same sentence, but this week they have been united in social media comments wondering how the country music queen would have allo
Moderna (MRNA) Gains But Lags Market: What You Should Know
09:45pm, Thursday, 28'th Apr 2022 Zacks Investment Research
Moderna (MRNA) closed at $142.52 in the latest trading session, marking a +0.06% move from the prior day.
The Daily Biotech Pulse: Moderna Seeks FDA Approval For COVID-19 Shot For Children 2-6, Tax Disclosure For Amgen, Fast Track Tags For SQZ Biotech, Timber Pharma Candidates
12:52pm, Thursday, 28'th Apr 2022 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours:
Stocks In Focus
Moderna Seeks FDA Emergency Use Nod For COVID-19 Shot In Kids 2-6
Moderna Inc (NASDAQ: MRNA) submitt
Moderna (MRNA) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
07:03pm, Wednesday, 27'th Apr 2022 Zacks Investment Research
Moderna (MRNA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
These 21 large-cap stocks have now crashed at least 50%
01:20pm, Wednesday, 27'th Apr 2022 MarketWatch
Pummeled stocks include Netflix, PayPal and Facebook parent Meta Platforms.
Will Biogen (BIIB) Succeed in Beating Q1 Earnings Estimates?
12:35pm, Wednesday, 27'th Apr 2022 Zacks Investment Research
Biogen's (BIIB) multiple sclerosis revenues have been declining since the past few quarters. It is unlikely that MS sales have improved in the first quarter.
Does This News From Novavax Mean Trouble for Moderna?
10:00am, Wednesday, 27'th Apr 2022 The Motley Fool
It could put Novavax a step ahead in a post-pandemic world.
U.S. stocks end higher as Dow, S&P 500, Nasdaq score biggest weekly gains since November 2020
07:45pm, Friday, 18'th Mar 2022 MarketWatch
U.S. stocks close higher, with all three major indexes booking their biggest weekly gains since November 2020, as investors took the Federal Reserve's interest rate hike and uncertainty over the Russi
Moderna wants to offer all adults a second booster, and HHS chief laments lack of funding for Biden ‘test to treat’ strategy
04:30pm, Friday, 18'th Mar 2022 MarketWatch
Moderna Inc. has asked the U.S. Food and Drug Administration to authorize a fourth shot of its COVID-19 vaccine as a booster shot for all adults, a broader request than that made by Pfizer earlier thi
1 Biotech Stock Investors Should Know About
03:00pm, Friday, 18'th Mar 2022 The Motley Fool
It's selling shovels amid the gold rush in mRNA medicines.
